These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 26084067

  • 1. Long-detection interval for ICDs helps avoid harmful shocks.
    Harv Heart Lett; 2014 Nov; 25(3):8. PubMed ID: 26084067
    [No Abstract] [Full Text] [Related]

  • 2. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.
    Kuck KH.
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):713-20; discussion 720. PubMed ID: 20009082
    [No Abstract] [Full Text] [Related]

  • 3. Catastrophic failure of Durata ICD lead due to high-voltage short during shock delivery.
    Schloss EJ, Krebs ME, Gupta M.
    Heart Rhythm; 2014 Oct; 11(10):1733-4. PubMed ID: 24931635
    [No Abstract] [Full Text] [Related]

  • 4. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia ablation versus drugs for preventing ICD shocks: role of adjuvant antiarrhythmic drug therapy.
    Patel C, Yan GX, Kocovic D, Kowey PR.
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):705-11; discussion 712. PubMed ID: 20009081
    [No Abstract] [Full Text] [Related]

  • 5. Antitachycardia pacing therapy for the successful treatment of lead fracture.
    Bhimani AA, Deeprasertkul P, Nannapaneni N, Carayannopoulos GN.
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):228-9. PubMed ID: 25354719
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy of long detection interval implantable cardioverter-defibrillator settings in secondary prevention population: data from the Avoid Delivering Therapies for Nonsustained Arrhythmias in ICD Patients III (ADVANCE III) trial.
    Kloppe A, Proclemer A, Arenal A, Lunati M, Martìnez Ferrer JB, Hersi A, Gulaj M, Wijffels MC, Santi E, Manotta L, Mangoni L, Gasparini M.
    Circulation; 2014 Jul 22; 130(4):308-14. PubMed ID: 24838360
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis.
    Kron J, Sauer W, Schuller J, Bogun F, Crawford T, Sarsam S, Rosenfeld L, Mitiku TY, Cooper JM, Mehta D, Greenspon AJ, Ortman M, Delurgio DB, Valadri R, Narasimhan C, Swapna N, Singh JP, Danik S, Markowitz SM, Almquist AK, Krahn AD, Wolfe LG, Feinstein S, Ellenbogen KA.
    Europace; 2013 Mar 22; 15(3):347-54. PubMed ID: 23002195
    [Abstract] [Full Text] [Related]

  • 10. An unusual case of impossible communication between an ICD and programmer.
    Attanasio P, Wutzler A, Huemer M, Parwani AS, Boldt LH, Haverkamp W, Blaschke F.
    J Cardiovasc Electrophysiol; 2015 Feb 22; 26(2):230. PubMed ID: 25257919
    [No Abstract] [Full Text] [Related]

  • 11. The burden of inappropriate shocks in young people and how to avoid them.
    Upadhyay GA, Mela T, Singh JP.
    Heart; 2012 Oct 22; 98(19):1457-66. PubMed ID: 22965797
    [No Abstract] [Full Text] [Related]

  • 12. Combining shock reduction strategies to enhance ICD therapy: a role for computer modeling.
    Volosin KJ, Exner DV, Wathen MS, Sherfesee L, Scinicariello AP, Gillberg JM.
    J Cardiovasc Electrophysiol; 2011 Mar 22; 22(3):280-9. PubMed ID: 20958831
    [Abstract] [Full Text] [Related]

  • 13. Seventh try's a charm: ventricular fibrillation terminated by the seventh shock.
    Li J, Zitron E, Katus HA, Becker R.
    Circ Arrhythm Electrophysiol; 2011 Apr 22; 4(2):e4-6. PubMed ID: 21505170
    [No Abstract] [Full Text] [Related]

  • 14. Safety and efficacy of strategic implantable cardioverter-defibrillator programming to reduce the shock delivery burden in a primary prevention patient population.
    Buber J, Luria D, Gurevitz O, Bar-Lev D, Eldar M, Glikson M.
    Europace; 2014 Feb 22; 16(2):227-34. PubMed ID: 24108231
    [Abstract] [Full Text] [Related]

  • 15. Atrial fibrillation in patients with implantable defibrillators.
    Sakhuja R, Shah AJ, Keebler M, Thakur RK.
    Cardiol Clin; 2009 Feb 22; 27(1):151-61, ix-x. PubMed ID: 19111771
    [Abstract] [Full Text] [Related]

  • 16. [Inappropriate therapy of an implantable cardioverter-defibrillator--is it always an undesired event?].
    Oreziak A, Przybylski A.
    Kardiol Pol; 2009 Aug 22; 67(8):930-1. PubMed ID: 19885986
    [No Abstract] [Full Text] [Related]

  • 17. Transvenous ICD lead malposition in the left ventricle: long-term follow-up.
    Franck H, Wollschläger H.
    Clin Res Cardiol; 2013 Feb 22; 102(2):159-61. PubMed ID: 22868694
    [No Abstract] [Full Text] [Related]

  • 18. Post-shock oversensing by a subcutaneous defibrillator resulting in inappropriate withholding of post-shock bradycardia pacing.
    Maass AH, Van Gelder IC.
    Europace; 2014 Jul 22; 16(7):1032. PubMed ID: 24792457
    [No Abstract] [Full Text] [Related]

  • 19. The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention.
    Olde Nordkamp LR, Wilde AA, Tijssen JG, Knops RE, van Dessel PF, de Groot JR.
    Circ Arrhythm Electrophysiol; 2013 Feb 22; 6(1):91-100. PubMed ID: 23275262
    [Abstract] [Full Text] [Related]

  • 20. Is defibrillation testing necessary for implantable transvenous defibrillators?: defibrillation testing is necessary at the time of implantable cardioverter defibrillator implantation.
    Russo AM, Chung MK.
    Circ Arrhythm Electrophysiol; 2014 Apr 22; 7(2):337-46. PubMed ID: 24736423
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.